Literature DB >> 18947653

Wilms' tumour with persistent intravascular extension: a review of the surgical aspects of management.

G V Murthi1, E Kocyildirim, S Sellathury, P M Cuckow, D T Wilcox, A Michalski, N J Sebire, M J Elliott, P G Duffy.   

Abstract

AIM: To review the surgical management of Wilms' tumour with persistent intravascular (vena caval +/- atrial) tumour extension. PATIENTS AND METHODS: Data were collected regarding operative details, tumour and 'thrombus' histology, and long-term outcome for patients with Wilms' tumour with cavo-artial extension. RESULT: From 1988 to 2004, 13 patients underwent treatment for Wilms' tumour with persistent intravascular extension. Preoperative chemotherapy was administered in 11/13 patients and postoperative radiotherapy in eight patients. Intravascular involvement was upto IVC (5), and right atrium (8) patients. Techniques employed for excision of intra-vascular component were: local cavotomy (3), extensive infra-diaphragmatic cavotomy without cardiopulmonary bypass (CPB) (1), and excision of cavo-atrial tumour with CPB (+/- hypothermia and cardiac arrest) (9). Mean time on CPB was 90 min. Caval repair was accomplished by primary repair (6) and pericardial graft in (7) patients. There were no intraoperative deaths and few major complications. Tumour thrombus contained malignant cells in 10/13 cases. Mean follow up has been for 55.4 months. To date, seven patients remain disease-free (one lost to follow up), disease recurred in five patients, three of whom have died. There were no symptoms related to the graft.
CONCLUSIONS: Surgery for Wilms' tumour with persistent intravascular extension despite chemotherapy is technically challenging. CPB +/- hypothermia and cardiac arrest and extensive caval repair with a graft is safe and reliable in the long term.

Entities:  

Year:  2005        PMID: 18947653     DOI: 10.1016/j.jpurol.2005.10.004

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  11 in total

1.  The enduring patency of primary inferior vena cava repair.

Authors:  Neel A Mansukhani; George E Havelka; Irene B Helenowski; Heron E Rodriguez; Andrew W Hoel; Mark K Eskandari
Journal:  Surgery       Date:  2016-12-20       Impact factor: 3.982

2.  Pediatric clear cell sarcoma of the kidney with atriocaval thrombus.

Authors:  Mehran Hiradfar; Nona Zabolinejad; Reza Shojaeian; Parisa Saeedi; Marjan Joodi; Reza Nazarzadeh; Hamid Farhangi; Mohammad Abbasi Tashnizi; Seyed Ali Alamdaran
Journal:  Pediatr Surg Int       Date:  2012-08-22       Impact factor: 1.827

Review 3.  Wilms tumor.

Authors:  Andrew M Davidoff
Journal:  Adv Pediatr       Date:  2012

4.  A surgical approach to Wilms' tumour with retrohepatic vena caval extension.

Authors:  Mohammad I Bader; Khaled Abdelaal; Timothy Rogers; Suren G Arul
Journal:  Pediatr Surg Int       Date:  2013-01-24       Impact factor: 1.827

Review 5.  Wilms' tumor.

Authors:  Andrew M Davidoff
Journal:  Curr Opin Pediatr       Date:  2009-06       Impact factor: 2.856

6.  Surgical management and outcomes of 12 cases of Wilms tumour with intracardiac extension from a single centre.

Authors:  Sharon G Cox; A Davidson; J Thomas; A Brooks; J Hewitson; A Numanoglu; A J W Millar
Journal:  Pediatr Surg Int       Date:  2017-10-11       Impact factor: 1.827

7.  Wilms tumor with intravascular tumor thrombus.

Authors:  Suna Emir
Journal:  Transl Pediatr       Date:  2014-01

Review 8.  Wilms' tumor with intravascular extension: A review article.

Authors:  Suzanne McMahon; Robert Carachi
Journal:  J Indian Assoc Pediatr Surg       Date:  2014-10

9.  Management of Wilms tumor with intravenous thrombus in children: a single center experience.

Authors:  Shuai Xu; Ning Sun; Wei-Ping Zhang; Hong-Cheng Song; Cheng-Ru Huang
Journal:  World J Pediatr       Date:  2019-06-03       Impact factor: 2.764

10.  Impact of neoadjuvant chemotherapy on thrombus viability in patients with Wilms tumour and caval extension: systematic review with meta-analysis.

Authors:  T D Boam; M Gabriel; R Shukla; P D Losty
Journal:  BJS Open       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.